Cingulate (CINGW) Notes Payables (2022 - 2026)
Cingulate's (CINGW) quarterly Notes Payables came in at $5.1 million in Q2 2026, down 19.52% quarter-over-quarter from $6.3 million in Q4 2025.
Analysis
Cingulate (CINGW) Notes Payables (2022 - 2026) Analysis & Trends
Cingulate (CINGW) has reported Notes Payables for 5 consecutive years, with $5.1 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Notes Payables changed N/A year-over-year to $5.1 million; the trailing twelve-month figure through Jun 2026 stood at $5.1 million (changed N/A YoY), and the FY2025 full-year result was $6.3 million, up 149.14% from the prior year.
- Notes Payables declined to $5.1 million in Q2 2026 per CINGW's latest filing, from $6.3 million in the prior quarter.
- Across five years, Notes Payables topped out at $8.0 million in Q2 2023 and bottomed at $2.5 million in Q4 2024.
- Historically, Notes Payables has averaged $4.6 million across 5 years, with a median of $5.0 million in 2022.
- The sharpest annual moves came in 2023 and 2025: Notes Payables sank 40.0% in 2023, then jumped 149.14% in 2025.
- Over 5 years, Notes Payables stood at $5.0 million in 2022, then tumbled by 40.0% to $3.0 million in 2023, then retreated by 15.76% to $2.5 million in 2024, then surged by 149.14% to $6.3 million in 2025, then slipped by 19.52% to $5.1 million in 2026.
- According to Business Quant data, Notes Payables over the past three periods registered $5.1 million, $6.3 million, and $3.2 million for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 644.46 Bn | 623.70 Bn | 17.26 Bn |
| 2 | AbbVie | 440.11 Bn | 433.54 Bn | 12.70 Bn |
| 3 | Merck | 365.04 Bn | 357.90 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.82 Bn | 259.13 Bn | 11.24 Bn |
| 5 | Pfizer | 159.14 Bn | 147.45 Bn | 10.94 Bn |
| 6 | Sanofi | 52.47 Bn | 45.09 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 44.26 Bn | 44.26 Bn | - |
| 8 | Incyte | 25.32 Bn | 20.79 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.46 Bn | 18.80 Bn | 683.80 Mn |
| 10 | Cingulate | 100,214.03 | 100,214.03 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.07 Mn |
| Dec 31, 2025 | 6.30 Mn |
| Sep 30, 2025 | 3.18 Mn |
| Mar 31, 2025 | 4.12 Mn |
| Dec 31, 2024 | 2.53 Mn |
| Dec 31, 2023 | 3.00 Mn |
| Sep 30, 2023 | 3.00 Mn |
| Jun 30, 2023 | 8.00 Mn |
| Mar 31, 2023 | 5.00 Mn |
| Dec 31, 2022 | 5.00 Mn |
| Sep 30, 2022 | 5.00 Mn |